The doctor warned about the risks of vaccines start from COVID-19 before the end of the test

The rush of the developers of the vaccine COVID-19 is justified by the seriousness of the pandemic, with most laboratories adhere to regulations for the mandatory phase three clinical testing of a vaccine, because the correct vaccine is the only solution to the pandemic, said in an interview with RIA Novosti Israeli immunologist, Professor Jacob Berman.

Formerly Director of the Institute for translational medicine and biotechnology sechenovskiy University Vadim Tarasov told RIA Novosti that the study of coronavirus vaccine on volunteers in Sechenovskiy University was successfully completed, the first group of volunteers will be discharged on Wednesday, the second on 20 July.

“I understand that the messages sechenovskiy Institute indicates that they have completed the first phase of the study. There are only three phases of research… Always the first phase is done on a small number of subjects. And always it is done with healthy people. The purpose of the first phase — the primary results regarding vaccine safety. Watch that they do not have serious side effects” — told the RIA Novosti Israeli Professor.

The development of a vaccine in the world at the moment engaged in hundreds of laboratories. Of these, about 140 are in preclinical phase, testing the effect of the vaccine on animals, about 20 have moved to clinical phase trials in humans, and three or four research groups from China and the USA have reported the transition to the third phase of clinical trials on large numbers of people. The results of the previous phases have already been published in peer-reviewed journals.

“For example, in the journal Lancet had recently published the results of the development of the first stage of the Chinese scientists, they, like Russia, was not the side effects. But there was already been shown positive immunological response and antibodies total and neutralizing antibodies. And cell response. I think that the scientists of the Institute of sechenovskiy exactly the same results, only it was not yet a scientific publication. And usually the next stage is the second phase of the research”, — said Yakov Berkun.

The second phase of testing of the Russian vaccine against the coronavirus will last until 28 July, then the Gamalei Institute will apply for registration, reported RIA Novosti Director of the center for epidemiology Microbiology named Gamalei Alexander Ginzburg. Tests of a vaccine against coronavirus are conducted without any attempts to reduce the time of the study, in full accordance with the methodology stated in the Russian defense Ministry.